Ipilimumab is under clinical development by Bristol-Myers Squibb and currently in Phase II for Soft Tissue Sarcoma. According to GlobalData, Phase II drugs for Soft Tissue Sarcoma have a 26% phase ...

A Bristol Myers Squibb drug that was first in its class to hit a certain immunological target now has positive data from two pivotal tests in psoriatic arthritis that could support expanding use ...

In this article, we are going to take a look at where Bristol-Myers Squibb Company (NYSE:BMY) stands against the other cash-rich dividend stocks. Cash remains a critical asset, as companies with ...

But he wasn’t the person whose party people were talking about. At the center of all the hubbub was Squibb herself, holding court in an impressive show of grace and stamina for someone of any ...

But he wasn’t the person whose party people were talking about. That would be “Thelma” star June Squibb, who turned 95 on Nov. 6 and whose birthday blowout was a testament to how wide the ...

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Century Therapeutics entered the partnership three years ago. Bristol Myers Squibb is ending its drug development partnership with Philadelphia cell therapy company Century Therapeutics ...

Bristol-Myers Squibb Company (NYSE:BMY) has announced that it will be increasing its periodic dividend on the 3rd of February to $0.62, which will be 3.3% higher than last year's comparable ...

In this article, we are going to take a look at where Bristol-Myers Squibb Company (NYSE:BMY) stands against the other best dividend stocks for the long term. The allure of steady income remains a ...

Johnson & Johnson, Lilly, Bristol Myers Squibb and Sanofi have each implemented, or attempted to implement, radical modifications to how 340B operates by withholding discounts for certain ...